Phibro Animal Health Corporation Class A

€28.28
EUR
Last updated on --.
24h volume390.23K
24h highest30.0860 EUR
24h lowest28.1478 EUR
24h Price movement-2.35%

PAHC recent prices

24 Hours
-2.35%-€0.6794
30 days
-39.11%-€18.27
60 days
-38.04%-€17.46
90 days
-39.45%-€18.53

Key data

Previous close28.9648 EUR
Market cap1.18B EUR
Volume390.23K
P/E ratio14.400000
Dividend yield (TTM)0.01%
Dividend amount0.10320 EUR
Next ex-dividend dateJun 3, 2026
Next payment dateJun 24, 2026
EPS diluted (TTM)2.0210 EUR
Net income (FY)81.90M EUR
Revenue (FY)1.29B EUR
Last report dateMay 6, 2026

About Phibro Animal Health Corporation Class A

PHARMACEUTICAL PREPARATIONS
HeadquartersTEANECK
Employees (FY)2.48K
Revenue per employee (FY)521.23K EUR
Net income per employee (FY)33.09K EUR
Listed onNasdaq
Official website

PAHC conversion tables

PAHCPAHC
EUREUR
0.5 PAHC14.14 EUR
1 PAHC28.28 EUR
5 PAHC141.42 EUR
10 PAHC282.85 EUR
EUREUR
PAHCPAHC
0.5 EUR0.017677 PAHC
1 EUR0.035354 PAHC
5 EUR0.17677 PAHC
10 EUR0.35354 PAHC

FAQ

PAHC is trading at €28.28, -2.35% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PAHC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PAHC is currently trading at €28.28, -2.35% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PAHC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PAHC's P/E ratio is currently 14.400000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PAHC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PAHC's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Phibro Animal Health Corporation Class A's market cap is currently 1.18B EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume390.23K
24h highest30.0860 EUR
24h lowest28.1478 EUR
24h Price movement-2.35%
PAHCPAHC
EUREUR
Start trade with PAHC Perpetual